ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery is a study focused on improving surgery for liver cancer, known as hepatocellular carcinoma. Doctors will use a special tool called fluorescence imaging to see cancer cells better during surgery. They are testing a probe that targets ITGA6, a protein found in high amounts in liver cancer cells. This study aims to see if this imaging method helps doctors remove cancer more accurately and safely.
Key Points:
- Participants should have liver cancer and be planning surgery.
- Participants must be between 18-80 years old and healthy enough to undergo surgery.
- Participants cannot be allergic to Cy7, a dye used in the study.
If you join, you might help improve future liver cancer surgeries. However, you need to meet certain health criteria and be able to tolerate surgery. This study is specially designed for those who have not joined other trials recently and have no other major health issues.